type-1-diabetes

Documents about type-1-diabetes

• Real-time Adaptation to Changes in Insulin Sensitivity#804540ClinicalTrials.gov
• A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®#195461ClinicalTrials.gov
• Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)#201722ClinicalTrials.gov
• Clinical Startup of the 670G Closed Loop Insulin Delivery System#238268ClinicalTrials.gov
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone#272289ClinicalTrials.gov
• Effect of Bile Acids on GLP-1 Secretion#272290ClinicalTrials.gov
• Switch of AndroidAPS to Commercially Available AID Systems#290903ClinicalTrials.gov
• Device Use Reimagined Through Education And Mentorship#307398ClinicalTrials.gov
• Assessing the Impact of Control-IQ Technology#332665ClinicalTrials.gov
• The Artificial Pancreas in Very Young Children With T1D#471565ClinicalTrials.gov
• NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes#628645ClinicalTrials.gov
• Non-compliance on Treatment Among Diabetic Students at Sohag University#628648ClinicalTrials.gov
• Gold and Clarke Questionnaires Identify Different People With Insulin‐Treated Diabetes and Impaired Awareness of Hypoglycaemia in Almost 60% of Cases: A Post Hoc Analysis From the Hypo‐ METRICS Study#178042HAL (France)
• Social Determinants of Health and Continuous Glucose Monitoring Metrics in Type 1 or Type 2 Diabetes.#338709NCBI PubMed Central
• Vivre et courir avec un diabète de type 1 : le soin en mouvement#350648HAL (France)
• Evaluating GLP-1 Receptor Agonist in the Treatment of Type 2 Diabetes: A Comparison of Medication Efficacy and Cost#183365BYU ScholarsArchive
• Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years#429684ClinicalTrials.gov
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period#356639ClinicalTrials.gov
• Predicting subclinical atherosclerosis in adults with type 1 diabetes using cardiovascular risk models: a cross‐sectional study from Italy#464448IRIS
• Effect of Needle-free Jet Injection of Insulin on Glucose Control and Injection Feelings in Type 1 Diabetic Patients#432850ClinicalTrials.gov
• Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)#141188ClinicalTrials.gov
• Depression, Obesity and Smoking were Independently Associated with Inadequate Glycemic Control in Patients with Type 1 Diabetes.#452344Lund University Publications
• Impact de la précarité des patients sur l'efficience hospitalière : le cas des patients adultes et pédiatriques hospitalisés pour un diabète de type 1#304648HAL (France)
• Microvascular Changes in OCT-angiography in Type 1 Diabetes Mellitus at the Onset of the Disease and After Optimization of Glycemic Control.#321645ClinicalTrials.gov
• The Impact of Socioeconomic Factors on the Development of Diabetes Complications among Patients with Type 2 DM#433346HAL (France)
• How effective are CBT and CBT-based interventions in Type 1 and Type 2 diabetes? An umbrella review.#8998NCBI PubMed Central
• Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM#807512ClinicalTrials.gov
• Single Hormone Closed Loop Study With PDT Sensor#18806ClinicalTrials.gov
• Insulin-based Strategies to Prevent Hypoglycemia During Exercise#28540ClinicalTrials.gov
• Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion#126009ClinicalTrials.gov
• GLP-1 and Non-exercise Activity Thermogenesis in RHZ#140950ClinicalTrials.gov
• FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)#140955ClinicalTrials.gov
• T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs#141165ClinicalTrials.gov
• Collection of Breath and Sweat to Identify Indicators of Hypoglycemia#141170ClinicalTrials.gov
• Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation#148668ClinicalTrials.gov
• Bone Marrow as an Alternative Site for Islet Transplantation#148672ClinicalTrials.gov
• An Outpatient Pump Shutoff Pilot Feasibility and Safety Study#162393ClinicalTrials.gov
• Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children#226198ClinicalTrials.gov
• Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System#230351ClinicalTrials.gov
• Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.#230352ClinicalTrials.gov
• Multiple Constrained MPCs for glucose regulation in Type 1 Diabetes#249195Zenodo (CERN)
• Matrix Metalloproteinases and Diabetic Nephropathy#261443ClinicalTrials.gov
• Galactose - the Ideal Carbohydrate Supplement for Exercise in Type 1 Diabetes#283167ClinicalTrials.gov
• Sleep Patterns and Chronotype in Children With and Without Type 1 Diabetes#303647ClinicalTrials.gov
• Effect of CSII and CGM on Progression of Late Diabetic Complications#321612ClinicalTrials.gov
• Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration#325246ClinicalTrials.gov
• Fracture Risk After Pancreas Transplantation (FraPaT)#337092ClinicalTrials.gov
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration#356621ClinicalTrials.gov
• Hypoglycemia Prediction in Type 1 Diabetes With Electrocardiography Beat Ensembles#372149PubMed Central
• GLP-1/Basal Insulin Combination Therapy#417471ClinicalTrials.gov